Abstract
BUSINESS Business Roundup ShareShare onFacebookTwitterWechatLinked InRedditEmail C&EN, 2023, 101 (13), p 17April 24, 2023Cite this:C&EN 101, 13, 17AbstractDSM has agreed to acquire Adare Biome, a French maker of postbiotics, for about $300 million. Postbiotics are inanimate microorganisms thought to deliver health benefits to humans and animals. Celanese will supply VitalDose, its ethylene vinyl acetate–based drug delivery technology, for use in Glaukos’s intraocular implant. The implant, which is not yet approved, delivers the glaucoma treatment travoprost. RWDC Industries has signed an agreement with Lummus Technology to market technology to make the biodegradable polymer polyhydroxyalkanoate. RWDC has a process to make the PHAs from plant based oils. Evonik Industries and Siemens Energy are collaborating on a green hydrogen pilot program in Herne, Germany. Siemens will provide an 8 MW electrolyzer, which will make both H 2 and oxygen for Evonik’s production of isophorone diamine. Chemours and TC Energy plan to collaborate on electrolytic hydrogen production in West Virginia. The firms plan to use proton exchange membranes from Chemours inView: PDF | Full Text HTML
Sign-in/Register to access full text options 
Free) 
Talk to us
Join us for a 30 min session where you can share your feedback and ask us any queries you have
Schedule a call
